• Online Features  This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (36)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Immunology  • Immunology, Other  • Alert me on articles by topic  Social Bookmarking   What's this?

Tanja Lange, MD; Stoyan Dimitrov, MSc; Horst-Lorenz Fehm, MD; Jürgen Westermann, MD; Jan Born, PhD

Arch Intern Med. 2006;166:1695-1700.

Background  Sleep is considered to strengthen immune defense. We hypothesized that sleep achieves this effect by shifting the balance between types 1 and 2 cytokine activity toward increased type 1 activity, thereby supporting adaptive cellular immune responses.

Methods  We analyzed monocyte-derived type 1 (interleukin 12 [IL-12]) and type 2 (IL-10) cytokines by means of multiparametric flow cytometry in healthy human subjects (n = 11) during a regular sleep-wake cycle and 24 hours of wakefulness.

Results  Sleep increased the number of IL-12–producing monocytes and concurrently decreased the number of IL-10–producing monocytes, thereby inducing clear rhythms in these cells, with maximum numbers at 2:20 and 11:30 AM, respectively. The rhythms were completely absent during continuous wakefulness. Correlation analyses and supplementary in vitro studies suggest that high prolactin and low cortisol levels are factors contributing to the shift in the IL-12/IL-10 ratio toward increased IL-12 activity during sleep.

Conclusions  Monocyte-derived IL-12 and IL-10 play a critical role for tuning the synapse between antigen-presenting cells and lymphocytes. By preferentially supporting type 1 IL-12 activity, sleep induces a 24-hour oscillation between predominant types 1 and 2 cytokines and, in this way, acts to globally increase the efficacy of adaptive immune responses. Improving sleep could represent a therapeutic option to enhance the success of vaccinations and success in the treatment of diseases (eg, atopic dermatitis and human immunodeficiency virus infection) that are characterized by type 2 cytokine overactivity.

Author Affiliations: Departments of Internal Medicine (Drs Lange and Fehm), Neuroendocrinology (Mr Dimitrov and Dr Born), and Anatomy (Dr Westermann), University of Lübeck, Lübeck, Germany.

CiteULike    Connotea    Delicious    Digg    Facebook    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Brain-immune interactions and the neural basis of disease-avoidant ingestive behaviour
Pacheco-Lopez and Bermudez-Rattoni
Phil Trans R Soc B 2011;366:3389-3405.
ABSTRACT | FULL TEXT  

Overnight Changes of Immune Parameters and Catecholamines Are Associated With Mood and Stress
Rief et al.
Psychosom. Med. 2010;72:755-762.
ABSTRACT | FULL TEXT  

Cross-sectional versus Prospective Associations of Sleep Duration with Changes in Relative Weight and Body Fat Distribution: The Whitehall II Study
Stranges et al.
Am J Epidemiol 2008;167:321-329.
ABSTRACT | FULL TEXT  

Sleeplessness Alters Immune Function
JWatch General 2006;2006:3-3.
FULL TEXT  

Sleep and health: everywhere and in both directions.
Zee and Turek
Arch Intern Med 2006;166:1686-1688.
FULL TEXT